Michael Henderson

A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era

Jennifer S Downs, Suren Subramanian, Michael A Henderson, Elizabeth Paton, Andrew J Spillane, Jon A Mathy, David E Gyorki

Journal article  |  2021  |  JOURNAL OF SURGICAL ONCOLOGY

BACKGROUND: The evidence-based management of melanoma patients with a positive sentinel lymph node biopsy (SLNB) has undergone a d..

Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study.

Andrea L Smith, Caroline G Watts, Samuel Robinson, Helen Schmid, Chris Goumas, Victoria J Mar, John F Thompson, Frances Rapport, undefined Australian Melanoma Centre of Research Excellence Study Group, Anne E Cust

Journal article  |  2021  |  Australas J Dermatol

BACKGROUND/OBJECTIVES: In melanoma management, sentinel lymph node biopsy (SLNB) is used to stage patients and to indicate prognos..

Melanoma Margins Trial (MelMarT-II): A Framework for Global Recruitment to a Large Multicentre Multinational Randomised Controlled Trial

D Gyorki, MD Moncrieff, RP Saw, AJ Spillane, R Olofsson Bagge, F Wright, J Dancey, JM Mammen, E Paton, N Williams, D Seminara, J Eguchi, MA Henderson

Conference Proceedings  |  2021  |  ANNALS OF SURGICAL ONCOLOGY

Radiation-associated breast cancers in a late-effects cohort: Long-term surveillance is essential

Eva Koo, Michael A Henderson, Mary Dwyer, Anita R Skandarajah

Journal article  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Aims Survivors of childhood, adolescent, and young adulthood malignancies have an increased risk of subsequent primary malignancie..

Diagnosis and management of cutaneous melanoma

Victoria J Mar, H Peter Soyer, Alison Button-Sloan, Paul Fishburn, David E Gyorki, Margaret Hardy, Michael Henderson, John F Thompson

Journal article  |  2020  |  AUSTRALIAN JOURNAL OF GENERAL PRACTICE

BACKGROUND: In the field of melanoma, clinical trials evaluating the impact of sentinel node biopsy, completion lymph node dissect..

Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study

Timothy J Kenyon-Smith, Hidde M Kroon, John T Miura, Juri Teras, Georgia M Beasley, Dean Mullen, Norma E Farrow, Paul J Mosca, Michael C Lowe, Clara R Farley, Aishwarya Potdar, Hala Daou, James Sun, Jeffrey M Farma, Michael A Henderson, David Speakman, Jonathan Serpell, Keith A Delman, B Mark Smithers, Andrew Barbour, et al.

Journal article  |  2020  |  EJSO

INTRODUCTION: Isolated limb infusion (ILI) is a minimally-invasive procedure for delivering high-dose regional chemotherapy to tre..

Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy

Hayden Snow, Catherine Mitchell, Shona Hendry, Madeleine McKinley, David Byrne, Sam Ngan, Sarat Chander, Julie Chu, Jayesh Desai, Susie Bae, Michael Henderson, Peter Choong, David Gyorki

Journal article  |  2020  |  JOURNAL OF SURGICAL ONCOLOGY

BACKGROUND AND OBJECTIVES: Limited literature exists examining the immune microenvironment in liposarcoma, particularly with regar..

Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia

Michael J Carr, James Sun, Hidde M Kroon, John T Miura, Georgia M Beasley, Norma E Farrow, Paul J Mosca, Michael C Lowe, Clara R Farley, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Dennis A Kirichenko, Aishwarya Potdar, Hala Daou, Dean Mullen, Jeffrey M Farma, Michael A Henderson, David Speakman, Jonathan Serpell, Keith A Delman, et al.

Journal article  |  2020  |  ANNALS OF SURGICAL ONCOLOGY

BACKGROUND: Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose chemotherapy to extremities af..

Cutaneous leiomyosarcoma: dermal and subcutaneous

Gwyneth Natalie Wong, Angela Webb, David Gyorki, Chris McCormack, Phillip Tran, Samuel Y Ngan, John Slavin, Michael A Henderson

Journal article  |  2020  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

BACKGROUND AND OBJECTIVES: Leiomyosarcoma of skin (LMS) can be sub-classified on pathology appearances as Dermal or Subcutaneous. ..

Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy

Jason Toppi, Yik Seng Tham, Angela Webb, Michael A Henderson, Danny Rischin, Matthew JR Magarey

Journal article  |  2020  |  ANZ JOURNAL OF SURGERY

BACKGROUND: Surgery is the primary treatment for patients with recurrent head and neck cutaneous squamous cell carcinoma (cSCC) wh..